Lymphomatoid granulomatosis

Source: Wikipedia, the free encyclopedia.
Lymphomatoid granulomatosis
SpecialtyHematology and oncology

Lymphomatoid granulomatosis (LYG or LG) is a very rare

granulomatosis denotes the microscopic characteristic of the presence of granulomas with polymorphic lymphoid infiltrates and focal necrosis
within it.

LG most commonly affects middle aged people,[2] but has occasionally been observed in young people.[3] Males are found to be affected twice as often as females.[4]

Causes

Lymphomatoid granulomatosis involves malignant

immunosuppressive drugs (with case reports of methotrexate[6][7][8][9][10][11][12][13][14] and azathioprine[15][16]), infections such as HIV or chronic viral hepatitis or endogenous T cell defects.[17]

Pathophysiology

The onset of the disease results in proliferation of EBV-infected malignant

seizures, unconsciousness and death, typically followed in that order.[17]

The disease has been seen to transform to diffuse large B-cell lymphoma[18] and while LG is graded I-III based on the number of large EBV-positive B-cells, grade II and III can be considered as a variant of T-cell rich diffuse large B-cell lymphoma.[4][19]

Treatment

Treatment depends on the grade (I-III) but typically consist of cortisone,

graft versus host disease after a second transplantation 4 years later. The remaining two patients died from sepsis after the transplantation.[21]

Prognosis

The current mortality is over 60% after 5 years. However, due to hematopoietic stem cell transplantation being performed only in recent years, this number could potentially be lowered in the future. In people with CNS involvement, treatment with Interferon alpha at the US National Cancer Institute resulted in complete remission in 90% of patients.[20]

See also

  • List of cutaneous conditions

References

External links